Omeprazol Basi (Omeprazole)

Omeprazol Basi is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining.
• Peptic ulcer disease: supports ulcer healing by reducing gastric acidity.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term non‑steroidal anti‑inflammatory drugs.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly lowers gastric acidity, providing a sustained reduction in stomach acid output and allowing mucosal healing.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: typically self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain or discomfort.
• Flatulence: mild bloating.
• Constipation: occasional.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation.
• Liver enzyme abnormalities: elevated ALT/AST.

When prescribing Omeprazol Basi, clinicians should consider several safety aspects.

• Assess renal and hepatic function: adjust use if impairment is present.
• Review long‑term therapy need: limit duration to the shortest effective period.
• Monitor for vitamin B12 deficiency: prolonged acid suppression may affect absorption.
• Caution in pregnancy and lactation: weigh benefits against potential risks.
• Avoid concomitant use with drugs that require acidic environment for absorption unless medically necessary.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atorvastatin: increased plasma concentrations, heightened risk of myopathy.
• Methotrexate: elevated levels, potential toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, monitor coagulation parameters.
• Digoxin: altered absorption, check serum levels.
• Phenytoin: reduced serum concentration, monitor seizure control.